Patent · US Expired

Aryl phosphate derivatives of d4T having anti-HIV activity

US6030957A · kind A · utility

15Cited by
3References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 30, 1998
Grant dateFeb 29, 2000
Priority date
Expiry dateJun 30, 2018

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07H19/20
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Aryl phosphate derivatives of d4T with para-bromo substitution on the aryl group show markedly increased potency as anti-HIV agents without undesirable levels of cytotoxic activity. In particular, these derivatives are potent inhibitors of HIV reverse transcriptase. In a preferred aspect of the present invention, the phosphorus of the aryl phosphate group is further substituted with an amino acid residue that may be esterified or substituted, such as a methoxy alaninyl group.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.